Beta Drugs (NSE:BETA) FCF Margin % : 8.52% (As of Mar. 2024)

View and export this data going back to 2017. Start your Free Trial

What is Beta Drugs FCF Margin %?

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Beta Drugs's Free Cash Flow for the six months ended in Mar. 2024 was ₹132 Mil. Beta Drugs's Revenue for the six months ended in Mar. 2024 was ₹1,544 Mil. Therefore, Beta Drugs's FCF Margin % for the quarter that ended in Mar. 2024 was 8.52%.

As of today, Beta Drugs's current FCF Yield % is 1.67%.

The historical rank and industry rank for Beta Drugs's FCF Margin % or its related term are showing as below:

NSE:BETA' s FCF Margin % Range Over the Past 10 Years
Min: -1647.92 Med: 3.92 Max: 17.45
Current: 6.53

During the past 12 years, the highest FCF Margin % of Beta Drugs was 17.45%. The lowest was -1647.92%. And the median was 3.92%.

NSE:BETA's FCF Margin % is ranked better than
68.46% of 1024 companies
in the Drug Manufacturers industry
Industry Median: 0.195 vs NSE:BETA: 6.53

Beta Drugs FCF Margin % Historical Data

The historical data trend for Beta Drugs's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Beta Drugs FCF Margin % Chart

Beta Drugs Annual Data

Trend

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

FCF Margin %

Get a 7-Day Free Trial

-7.58

11.06

5.55

2.28

6.53

Beta Drugs Semi-Annual Data
	Mar13	Mar14	Mar15	Mar16	Mar17	Sep17	Mar18	Sep18	Mar19	Sep19	Mar20	Sep20	Mar21	Sep21	Mar22	Sep22	Mar23	Sep23	Mar24
FCF Margin %	Get a 7-Day Free Trial														4.31	-0.02	4.52	4.35	8.52

Competitive Comparison of Beta Drugs's FCF Margin %

For the Drug Manufacturers - Specialty & Generic subindustry, Beta Drugs's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Beta Drugs's FCF Margin % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Beta Drugs's FCF Margin % distribution charts can be found below:

* The bar in red indicates where Beta Drugs's FCF Margin % falls into.

Beta Drugs FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

Beta Drugs's FCF Margin for the fiscal year that ended in Mar. 2024 is calculated as

FCF Margin	=	Free Cash Flow (A: Mar. 2024 )	/	Revenue (A: Mar. 2024 )
	=	193.145	/	2957.138
	=	6.53 %

Beta Drugs's FCF Margin for the quarter that ended in Mar. 2024 is calculated as

FCF Margin	=	Free Cash Flow (Q: Mar. 2024 )	/	Revenue (Q: Mar. 2024 )
	=	131.651	/	1544.452
	=	8.52 %

Beta Drugs FCF Margin % Related Terms

Thank you for viewing the detailed overview of Beta Drugs's FCF Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

Beta Drugs (NSE:BETA) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Beta Drugs Ltd (NSE:BETA) » Definitions » FCF Margin %

Traded in Other Exchanges

N/A

Address

SCO-184, First Floor, Sector-5, Panchkula, HR, IND, 134114

Website

https://www.betadrugslimited.com

Beta Drugs Ltd operates in the pharmaceutical industry. The company manufactures and sells Oncology products in the form of tablets, capsules, oral formulations, and injections. It sells the products in India and also exports it to other countries of which key revenue is derived from the sales made in India.

Beta Drugs (NSE:BETA) Headlines

No Headlines